{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T13:24:32Z","timestamp":1783430672909,"version":"3.54.6"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T00:00:00Z","timestamp":1533081600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Exp Nephrol"],"published-print":{"date-parts":[[2019,2]]},"DOI":"10.1007\/s10157-018-1621-z","type":"journal-article","created":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T02:15:43Z","timestamp":1533089743000},"page":"189-198","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Clinical prediction models for progression of chronic kidney disease to end-stage kidney failure under pre-dialysis nephrology care: results from the Chronic Kidney Disease Japan Cohort Study"],"prefix":"10.1007","volume":"23","author":[{"name":"on behalf of the CKD-JAC Study Investigators","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0420-5583","authenticated-orcid":false,"given":"Takeshi","family":"Hasegawa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kentaro","family":"Sakamaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fumihiko","family":"Koiwa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tadao","family":"Akizawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akira","family":"Hishida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,8,1]]},"reference":[{"key":"1621_CR1","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1111\/j.1523-1755.2005.00397.x","volume":"68","author":"T Ninomiya","year":"2005","unstructured":"Ninomiya T, Kiyohara Y, Kubo M, Tanizaki Y, Doi Y, Okubo K, Wakugawa Y, Hata J, Oishi Y, Shikata K, Yonemoto K, Hirakata H, Iida M. Chronic kidney disease and cardiovascular disease in a general Japanese population: the Hisayama Study. Kidney Int. 2005;68:228\u201336.","journal-title":"Kidney Int"},{"key":"1621_CR2","doi-asserted-by":"publisher","first-page":"2073","DOI":"10.1016\/S0140-6736(10)60674-5","volume":"375","author":"K Matsushita","year":"2010","unstructured":"Chronic Kidney Disease Prognosis Consortium. Matsushita K, van der Velde M, Astor BC, Woodward M, Levey AS, de Jong PE, Coresh J, Gansevoort RT. Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis. Lancet 2010;375:2073\u201381.","journal-title":"Lancet"},{"key":"1621_CR3","doi-asserted-by":"publisher","first-page":"2038","DOI":"10.1001\/jama.298.17.2038","volume":"298","author":"J Coresh","year":"2007","unstructured":"Coresh J, Selvin E, Stevens LA, Manzi J, Kusek JW, Eggers P, Van Lente F, Levey AS. Prevalence of chronic kidney disease in the United States. JAMA. 2007;298:2038\u201347.","journal-title":"JAMA"},{"key":"1621_CR4","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1038\/nrneph.2011.11","volume":"7","author":"WG Couser","year":"2011","unstructured":"Couser WG, Riella MC, Joint International Society of Nephrology and International Federation of Kidney Foundations World Kidney. Day 2011 steering committee: cardiovascular disease. world kidney day 2011: protect your kidneys, save your heart. Nat Rev Nephrol. 2011;7:130\u20132.","journal-title":"Nat Rev Nephrol"},{"key":"1621_CR5","doi-asserted-by":"publisher","first-page":"1975","DOI":"10.1016\/S0140-6736(14)61601-9","volume":"385","author":"T Liyanage","year":"2015","unstructured":"Liyanage T, Ninomiya T, Jha V, Neal B, Patrice HM, Okpechi I, Zhao MH, Lv J, Garg AX, Knight J, Rodgers A, Gallagher M, Kotwal S, Cass A, Perkovic V. Worldwide access to treatment for end-stage kidney disease: a systematic review. Lancet. 2015;385:1975\u201382.","journal-title":"Lancet"},{"key":"1621_CR6","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1111\/1744-9987.12281","volume":"18","author":"S Nakai","year":"2014","unstructured":"Nakai S, Hanafusa N, Masakane I, Taniguchi M, Hamano T, Shoji T, Hasegawa T, Itami N, Yamagata K, Shinoda T, Kazama JJ, Watanabe Y, Shigematsu T, Marubayashi S, Morita O, Wada A, Hashimoto S, Suzuki K, Nakamoto H, Kimata N, Wakai K, Fujii N, Ogata S, Tsuchida K, Nishi H, Iseki K, Tsubakihara Y. An overview of regular dialysis treatment in Japan (as of 31 December 2012). Ther Apher Dial. 2014;18:535\u2013602.","journal-title":"Ther Apher Dial"},{"key":"1621_CR7","doi-asserted-by":"publisher","first-page":"595","DOI":"10.2215\/CJN.03540708","volume":"4","author":"T Hasegawa","year":"2009","unstructured":"Hasegawa T, Bragg-Gresham JL, Yamazaki S, Fukuhara S, Akizawa T, Kleophas W, Greenwood R, Pisoni RL. Greater first-year survival on hemodialysis in facilities in which patients are provided earlier and more frequent pre-nephrology visits. Clin J Am Soc Nephrol. 2009;4:595\u2013602.","journal-title":"Clin J Am Soc Nephrol"},{"key":"1621_CR8","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1053\/j.ajkd.2011.11.044","volume":"59","author":"AM O\u2019Hare","year":"2012","unstructured":"O\u2019Hare AM, Batten A, Burrows NR, Pavkov ME, Taylor L, Gupta I, Todd-Stenberg J, Maynard C, Rodriguez RA, Murtagh FE, Larson EB, Williams DE. Trajectories of kidney function decline in the 2 years before initiation of long-term dialysis. Am J Kidney Dis. 2012;59:513\u201322.","journal-title":"Am J Kidney Dis"},{"key":"1621_CR9","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1038\/ki.2010.531","volume":"80","author":"RT Gansevoort","year":"2011","unstructured":"Gansevoort RT, Matsushita K, van der Velde M, Astor BC, Woodward M, Levey AS, de Jong PE, Coresh J, Chronic Kidney Disease Prognosis Consortium. Lower estimated GFR and higher albuminuria are associated with adverse kidney outcomes. A collaborative meta-analysis of general and high-risk population cohorts. Kidney Int. 2011;80:93\u2013104.","journal-title":"Kidney Int"},{"key":"1621_CR10","doi-asserted-by":"publisher","first-page":"1468","DOI":"10.1046\/j.1523-1755.2003.00868.x","volume":"63","author":"K Iseki","year":"2003","unstructured":"Iseki K, Ikemiya Y, Iseki C, Takishita S. Proteinuria and the risk of developing end-stage renal disease. Kidney Int. 2003;63:1468\u201374.","journal-title":"Kidney Int"},{"key":"1621_CR11","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1007\/s10157-016-1309-1","volume":"21","author":"D Inaguma","year":"2016","unstructured":"Inaguma D, Imai E, Takeuchi A, Ohashi Y, Watanabe T, Nitta K, Akizawa T, Matsuo S, Makino H, Hishida A, Chronic Kidney Disease Japan Cohort Study Group. Risk factors for CKD progression in Japanese patients: findings from the Chronic Kidney Disease Japan Cohort (CKD-JAC) study. Clin Exp Nephrol. 2016;21:446\u201356.","journal-title":"Clin Exp Nephrol"},{"key":"1621_CR12","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1038\/ki.2010.483","volume":"80","author":"AS Levey","year":"2011","unstructured":"Levey AS, de Jong PE, Coresh J, El Nahas M, Astor BC, Matsushita K, Gansevoort RT, Kasiske BL, Eckardt KU: The definition, classification, and prognosis of chronic kidney disease: a KDIGO Controversies Conference report. Kidney Int 2011;80:17\u201328.","journal-title":"Kidney Int"},{"key":"1621_CR13","doi-asserted-by":"publisher","first-page":"761","DOI":"10.2215\/CJN.01381005","volume":"1","author":"WF Keane","year":"2006","unstructured":"Keane WF, Zhang Z, Lyle PA, Cooper ME, de Zeeuw D, Grunfeld JP, Lash JP, McGill JB, Mitch WE, Remuzzi G, Shahinfar S, Snapinn SM, Toto R, Brenner BM. RENAAL Study Investigators: Risk scores for predicting outcomes in patients with type 2 diabetes and nephropathy: the RENAAL study. Clin J Am Soc Nephrol. 2006;1:761\u20137.","journal-title":"Clin J Am Soc Nephrol"},{"key":"1621_CR14","doi-asserted-by":"crossref","unstructured":"Jardine MJ, Hata J, Woodward M, Perkovic V, Ninomiya T, Arima H, Zoungas S, Cass A, Patel A, Marre M, Mancia G, Mogensen CE, Poulter N, Chalmers J. ADVANCE Collaborative Group: Prediction of kidney-related outcomes in patients with type 2 diabetes. Am J Kidney Dis 60:770\u2013778.","DOI":"10.1053\/j.ajkd.2012.04.025"},{"key":"1621_CR15","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1053\/j.ajkd.2008.04.026","volume":"52","author":"ES Johnson","year":"2008","unstructured":"Johnson ES, Thorp ML, Platt RW, Smith DH. Predicting the risk of dialysis and transplant among patients with CKD: a retrospective cohort study. Am J Kidney Dis. 2008;52:653\u201360.","journal-title":"Am J Kidney Dis"},{"key":"1621_CR16","doi-asserted-by":"publisher","first-page":"1553","DOI":"10.1001\/jama.2011.451","volume":"305","author":"N Tangri","year":"2011","unstructured":"Tangri N, Stevens LA, Griffith J, Tighiouart H, Djurdjev O, Naimark D, Levin A, Levey AS. A predictive model for progression of chronic kidney disease to kidney failure. JAMA. 2011;305:1553\u20139.","journal-title":"JAMA"},{"key":"1621_CR17","doi-asserted-by":"publisher","first-page":"1773","DOI":"10.1093\/ndt\/gft063","volume":"28","author":"MJ Peeters","year":"2013","unstructured":"Peeters MJ, van Zuilen AD, van den Brand JA, Bots ML, Blankestijn PJ, Wetzels JF, MASTERPLAN Study Group. Validation of the kidney failure risk equation in European CKD patients. Nephrol Dial Transplant. 2013;28:1773\u20139.","journal-title":"Nephrol Dial Transplant"},{"key":"1621_CR18","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1001\/jama.2015.18202","volume":"315","author":"N Tangri","year":"2016","unstructured":"Tangri N, Grams ME, Levey AS, Coresh J, Appel LJ, Astor BC, Chodick G, Collins AJ, Djurdjev O, Elley CR, Evans M, Garg AX, Hallan SI, Inker LA, Ito S, Jee SH, Kovesdy CP, Kronenberg F, Heerspink HJ, Marks A, Nadkarni GN, Navaneethan SD, Nelson RG, Titze S, Sarnak MJ, Stengel B, Woodward M, Iseki K. CKD prognosis consortium: multinational assessment of accuracy of equations for predicting risk of kidney failure: a meta-analysis. JAMA. 2016;315:164\u201374.","journal-title":"JAMA"},{"key":"1621_CR19","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1291\/hypres.30.55","volume":"30","author":"K Iseki","year":"2007","unstructured":"Iseki K, Kohagura K, Sakima A, Iseki C, Kinjo K, Ikemiya Y, Takishita S. Changes in the demographics and prevalence of chronic kidney disease in Okinawa, Japan (1993 to 2003). Hypertens Res. 2007;30:55\u201362.","journal-title":"Hypertens Res"},{"key":"1621_CR20","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1007\/s10157-010-0295-y","volume":"14","author":"M Nakayama","year":"2010","unstructured":"Nakayama M, Sato T, Sato H, Yamaguchi Y, Obara K, Kurihara I, Sato K, Hotta O, Seino J, Miyata M, Takeuchi K, Nakayama K, Matsushima M, Otaka T, Kinoshita Y, Taguma Y, Ito S. Different clinical outcomes for cardiovascular events and mortality in chronic kidney disease according to underlying renal disease: the Gonryo study. Clin Exp Nephrol. 2010;14:333\u20139.","journal-title":"Clin Exp Nephrol"},{"key":"1621_CR21","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1291\/hypres.31.1101","volume":"31","author":"E Imai","year":"2008","unstructured":"Imai E, Matsuo S, Makino H, Watanabe T, Akizawa T, Nitta K, Iimuro S, Ohashi Y, Hishida A, CKD-JAC Study Group. Chronic kidney disease Japan cohort (CKD-JAC) study: design and methods. Hypertens Res. 2008;31:1101\u20137.","journal-title":"Hypertens Res"},{"key":"1621_CR22","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1007\/s10157-010-0328-6","volume":"14","author":"E Imai","year":"2010","unstructured":"Imai E, Matsuo S, Makino H, Watanabe T, Akizawa T, Nitta K, Iimuro S, Ohashi Y, Hishida A. Chronic Kidney Disease Japan Cohort Study: baseline characteristics and factors associated with causative diseases and renal function. Clin Exp Nephrol. 2010;14:558\u201370.","journal-title":"Clin Exp Nephrol"},{"key":"1621_CR23","doi-asserted-by":"publisher","first-page":"2600","DOI":"10.1681\/ASN.2006080936","volume":"18","author":"D Fliser","year":"2007","unstructured":"Fliser D, Kollerits B, Neyer U, Ankerst DP, Lhotta K, Lingenhel A, Ritz E, Kronenberg F, MMKD Study Group, Kuen E, K\u00f6nig P, Kraatz G, Mann JF, M\u00fcller GA, K\u00f6hler H, Riegler P. Fibroblast Growth Factor 23 (FGF23) predicts progression of chronic kidney disease: the Mild to Moderate Kidney Disease [24] Study. J Am Soc Nephrol. 2007;18:2600\u20138.","journal-title":"J Am Soc Nephrol"},{"key":"1621_CR24","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1159\/000454959","volume":"45","author":"C Xue","year":"2016","unstructured":"Xue C, Yang B, Zhou C, Dai B, Liu Y, Mao Z, Yu S, Mei C. Fibroblast Growth Factor 23 predicts all-cause mortality in a dose-response fashion in pre-dialysis patients with chronic kidney disease. Am J Nephrol. 2016;45:149\u201359.","journal-title":"Am J Nephrol"},{"key":"1621_CR25","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1016\/j.kint.2016.10.021","volume":"91","author":"J Munoz Mendoza","year":"2016","unstructured":"Munoz Mendoza J, Isakova T, Cai X, Bayes LY, Faul C, Scialla JJ, Lash JP, Chen J, He J, Navaneethan S, Negrea L, Rosas SE, Kretzler M, Nessel L, Xie D, Anderson AH, Raj DS, Wolf M, CRIC Study Investigators. Inflammation and elevated levels of fibroblast growth factor 23 are independent risk factors for death in chronic kidney disease. Kidney Int. 2016;91:711\u20139.","journal-title":"Kidney Int"},{"key":"1621_CR26","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1053\/j.ajkd.2008.12.034","volume":"53","author":"S Matsuo","year":"2009","unstructured":"Matsuo S, Imai E, Horio M, Yasuda Y, Tomita K, Nitta K, Yamagata K, Tomino Y, Yokoyama H, Hishida A. Collaborators developing the Japanese equation for estimated GFR: Revised equations for estimated GFR from serum creatinine in Japan. Am J Kidney Dis. 2009;53:982\u201392.","journal-title":"Am J Kidney Dis"},{"key":"1621_CR27","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1002\/bjs.9736","volume":"102","author":"GS Collins","year":"2015","unstructured":"Collins GS, Reitsma JB, Altman DG, Moons KGM. Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD): the TRIPOD statement. Br J Surg. 2015;102:148\u201358.","journal-title":"Br J Surg"},{"key":"1621_CR28","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1111\/j.0006-341X.2005.030814.x","volume":"61","author":"PJ Heagerty","year":"2005","unstructured":"Heagerty PJ, Zheng Y. Survival model predictive accuracy and ROC curves. Biometrics. 2005;61:92\u2013105.","journal-title":"Biometrics"},{"key":"1621_CR29","volume-title":"Evaluation of the performance of survival analysis models: discrimination and calibration measures","author":"RBNB D\u2019Agostino","year":"2004","unstructured":"D\u2019Agostino RBNB. Evaluation of the performance of survival analysis models: discrimination and calibration measures. San Francisco: Elsevier; 2004."},{"key":"1621_CR30","doi-asserted-by":"publisher","first-page":"2389","DOI":"10.1002\/sim.2712","volume":"26","author":"H Putter","year":"2007","unstructured":"Putter H, Fiocco M, Geskus RB. Tutorial in biostatistics: competing risks and multi-state models. Stat Med. 2007;26:2389\u2013430.","journal-title":"Stat Med"},{"key":"1621_CR31","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1038\/ki.2008.261","volume":"74","author":"K Iseki","year":"2008","unstructured":"Iseki K. Gender differences in chronic kidney disease. Kidney Int. 2008;74:415\u20137.","journal-title":"Kidney Int"},{"key":"1621_CR32","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1053\/j.ajkd.2013.08.028","volume":"63","author":"W Yang","year":"2014","unstructured":"Yang W, Xie D, Anderson AH, Joffe MM, Greene T, Teal V, Hsu CY, Fink JC, He J, Lash JP, Ojo A, Rahman M, Nessel L, Kusek JW, Feldman HI, CRIC Study Investigators. Association of kidney disease outcomes with risk factors for CKD: findings from the Chronic Renal Insufficiency Cohort (CRIC) study. Am J Kidney Dis. 2014;63:236\u201343.","journal-title":"Am J Kidney Dis"},{"key":"1621_CR33","doi-asserted-by":"publisher","first-page":"2432","DOI":"10.1001\/jama.2011.826","volume":"305","author":"T Isakova","year":"2011","unstructured":"Isakova T, Xie H, Yang W, Xie D, Anderson AH, Scialla J, Wahl P, Guti\u00e9rrez OM, Steigerwalt S, He J, Schwartz S, Lo J, Ojo A, Sondheimer J, Hsu CY, Lash J, Leonard M, Kusek JW, Feldman HI, Wolf M. Chronic Renal Insufficiency Cohort (CRIC) Study Group: Fibroblast growth factor 23 and risks of mortality and end-stage renal disease in patients with chronic kidney disease. JAMA. 2011;305:2432\u20139.","journal-title":"JAMA"},{"key":"1621_CR34","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1681\/ASN.2014020218","volume":"26","author":"CM Rebholz","year":"2015","unstructured":"Rebholz CM, Grams ME, Coresh J, Selvin E, Inker LA, Levey AS, Kimmel PL, Vasan RS, Eckfeldt JH, Feldman HI, Hsu CY, Lutsey PL. Chronic kidney disease biomarkers consortium: serum fibroblast growth factor-23 is associated with incident kidney disease. J Am Soc Nephrol. 2015;26:192\u2013200.","journal-title":"J Am Soc Nephrol"},{"key":"1621_CR35","doi-asserted-by":"publisher","first-page":"2518","DOI":"10.1001\/jama.2014.6634","volume":"311","author":"J Coresh","year":"2014","unstructured":"Coresh J, Turin T, Matsushita K, Sang Y, Ballew SH, Appel LJ, Arima H, Chadban SJ, Cirillo M, Djurdjev O, Green JA, Heine GH, Inker LA, Irie F, Ishani A, Ix JH, Kovesdy CP, Marks A, Ohkubo T, Shalev V, Shankar A, Wen CP, de Jong PE, Iseki K, Stengel B, Gansevoort RT, Levey AS. Decline in estimated glomerular filtration rate and subsequent risk of end-stage renal disease and mortality. JAMA. 2014;311:2518\u201331.","journal-title":"JAMA"},{"key":"1621_CR36","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1016\/j.kint.2016.09.037","volume":"91","author":"JJ Carrero","year":"2017","unstructured":"Carrero JJ, Grams ME, Sang Y, \u00c4rnl\u00f6v J, Gasparini A, Matsushita K, Qureshi AR, Evans M, Barany P, Lindholm B, Ballew SH, Levey AS, Gansevoort RT, Elinder CG, Coresh J. Albuminuria changes are associated with subsequent risk of end-stage renal disease and mortality. Kidney Int. 2017;91:244\u201351.","journal-title":"Kidney Int"}],"container-title":["Clinical and Experimental Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10157-018-1621-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10157-018-1621-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10157-018-1621-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,29]],"date-time":"2019-08-29T13:22:52Z","timestamp":1567084972000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10157-018-1621-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8,1]]},"references-count":36,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019,2]]}},"alternative-id":["1621"],"URL":"https:\/\/doi.org\/10.1007\/s10157-018-1621-z","relation":{},"ISSN":["1342-1751","1437-7799"],"issn-type":[{"value":"1342-1751","type":"print"},{"value":"1437-7799","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,8,1]]},"assertion":[{"value":"2 March 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 July 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 August 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"TH has consulted for and received lecture fees from Kyowa Hakko Kirin; FK has received speaker honoraria and a support grant from Kyowa Hakko Kirin; and TA has consulted for and received lecture fees from Kyowa Hakko Kirin. The other authors have nothing to declare.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures in the CKD-JAC study were approved by the institutional review board (IRB) in each facility (IRB approval number 2007578 in Showa University Fujigaoka Hospital) and were performed per the Helsinki Declaration and its later amendments or comparable ethical standards.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and animal rights"}},{"value":"Informed consent was obtained for each participant in accordance with the requirements of IRB and facility.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}